Optimizing Treatment of Tumors Using Nanoparticle-Based Medication Delivery Systems
Keywords:
Drug loading rate, biocompatibility, tumors, nanoparticleAbstract
Recent years have seen a substantial increase in interest in using nanoparticles in treating tumors because of their potential to maximize therapeutic results while minimizing adverse effects. Targeted treatment is made possible by the ability of nanoparticles to deliver medications directly to tumor locations. They may specifically attach to tumor cells by functionalizing the nanoparticle's surface with targeting ligands, boosting drug accumulation in the tumor, and minimizing exposure to healthy tissues. Nanoparticles may also make anticancer medications more stable and soluble, facilitating their efficient distribution. Nanoparticle-based therapy, commonly referred to as nanomedicine or nanoparticle-based therapy, is a young area with great promise. When therapeutic drugs are delivered selectively to tumour areas using nanoparticle technology, therapy effectiveness is increased and adverse effects are reduced. Applications for nanoparticle delivery systems in the medical management of different illnesses, particularly cancer therapy, seem promising. Drug distribution is controlled through the characteristics of nanoparticles. The structure of nanoparticles has become the topic of several research in the last few decades, and significant progress has been achieved in this area. To offer conceptual advice regarding subsequent drug delivery of nanoparticles, the article supplied optimization strategies for nanoparticles in three perspectives: improving biocompatibility, targeting effectiveness, and expanding drug loading rate.
Downloads
References
Silvestris, E., De Palma, G., Canosa, S., Palini, S., Dellino, M., Revelli, A. and Paradiso, A.V., 2020. Human ovarian cortex biobanking: a fascinating resource for fertility preservation in cancer. International Journal of Molecular Sciences, 21(9), p.3245.
Chetty, I.J. and Rosu-Bubulac, M., 2019, July. Deformable registration for dose accumulation. In Seminars in radiation oncology (Vol. 29, No. 3, pp. 198-208). WB Saunders.
Lin, X., Liu, S., Zhang, X., Zhu, R., Chen, S., Chen, X., Song, J. and Yang, H., 2020. An Ultrasound Activated Vesicle of Janus Au‐MnO Nanoparticles for Promoted Tumor Penetration and Sono‐Chemodynamic Therapy of Orthotopic Liver Cancer. Angewandte Chemie, 132(4), pp.1699-1705.
Wu, C., Jiang, P., Li, W., Guo, H., Wang, J., Chen, J., Prausnitz, M.R. and Wang, Z.L., 2020. Self‐powered iontophoretic transdermal drug delivery system driven and regulated by biomechanical motions. Advanced Functional Materials, 30(3), p.1907378.
Miao, Y., Feng, Y., Bai, J., Liu, Z. and Zhao, X., 2021. Optimized mesoporous silica nanoparticle-based drug delivery system with removable manganese oxide gatekeeper for controlled delivery of doxorubicin. Journal of Colloid and Interface Science, 592, pp.227-236.
Bajpai, S., Tiwary, S.K., Sonker, M., Joshi, A., Gupta, V., Kumar, Y., Shreyash, N. and Biswas, S., 2021. Recent advances in nanoparticle-based cancer treatment: a review. ACS Applied Nano Materials, 4(7), pp.6441-6470.
Dai, X., Du, T. and Han, K., 2019. Engineering nanoparticles for optimized photodynamic therapy. ACS Biomaterials Science & Engineering, 5(12), pp.6342-6354.
Chu, H., Zhao, J., Mi, Y., Di, Z. and Li, L., 2019. NIR-light-mediated spatially selective triggering of anti-tumor immunity via upconversion nanoparticle-based immunodevices. Nature communications, 10(1), p.2839.
Morton, S.W., Lee, M.J., Deng, Z.J., Dreaden, E.C., Siouve, E., Shopsowitz, K.E., Shah, N.J., Yaffe, M.B. and Hammond, P.T., 2014. A nanoparticle-based combination chemotherapy delivery system for enhanced tumor killing by dynamic rewiring of signaling pathways. Science signaling, 7(325), pp.ra44-ra44.
Staňková, K., Brown, J.S., Dalton, W.S. and Gatenby, R.A., 2019. We are optimizing cancer treatment using game theory: a review. JAMA Oncology, 5(1), pp.96-103.
Hu, K., Gan, Q., Zhang, Y., Deng, S., Xiao, F., Huang, W., Cao, C. and Gao, X., 2019. Brain tumor segmentation using multi-cascaded convolutional neural networks and conditional random field. IEEE Access, 7, pp.92615-92629.
Yong, T., Zhang, X., Bie, N., Zhang, H., Zhang, X., Li, F., Hakeem, A., Hu, J., Gan, L., Santos, H.A. and Yang, X., 2019. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy. Nature communications, 10(1), p.3838.
Narmatha, C., Eljack, S.M., Tuka, A.A.R.M., Manimurugan, S. and Mustafa, M., 2020. A hybrid fuzzy brain-storm optimization algorithm for classifying brain tumor MRI images. Journal of ambient intelligence and humanized computing, pp.1-9.
Sharif, M., Amin, J., Raza, M., Yasmin, M. and Satapathy, S.C., 2020. An integrated particle swarm optimization (PSO) design with a fusion of features for detecting brain tumors. Pattern Recognition Letters, 129, pp.150-157.
Raja, P.S., 2020. Brain tumor classification using a hybrid deep autoencoder with a Bayesian fuzzy clustering-based segmentation approach. Biocybernetics and Biomedical Engineering, 40(1), pp.440-453.
Zhou, C., Ding, C., Wang, X., Lu, Z., and Tao, D., 2020. One-pass multi-task networks with cross-task guided attention for brain tumor segmentation. IEEE Transactions on Image Processing, 29, pp.4516-4529.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJISAE open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
